Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline

被引：0
|
作者：
Kong, Hui [1 ]
Bai, Qianming [1 ]
Lu, Hongfen [1 ]
Zhou, Xiaoyan [1 ]
Yang, Wentao [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
185
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations
    Hwang, Hye Won
    Hong, Soon Auck
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Yu, Jong-Han
    Lee, Se Kyung
    Cho, Soo Youn
    Cho, Eun Yoon
    VIRCHOWS ARCHIV, 2022, 480 (04) : 749 - 758
  • [42] The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines
    Yang, Libo
    Chen, Min
    Pu, Tianjie
    Wu, Shuang
    Wei, Bing
    Yang, Jieliang
    Bu, Hong
    Zhang, Zhang
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (05) : 283 - 290
  • [43] Impact of 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing: Increase in Equivocal Results and Utility of Reflex Immunohistochemistry
    Muller, Kristen
    Tafe, Laura
    Steinmetz, Heather
    Marotti, Jonathan
    LABORATORY INVESTIGATION, 2015, 95 : 57A - 57A
  • [44] Impact of 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing: Increase in Equivocal Results and Utility of Reflex Immunohistochemistry
    Muller, Kristen
    Tafe, Laura
    Steinmetz, Heather
    Marotti, Jonathan
    MODERN PATHOLOGY, 2015, 28 : 57A - 57A
  • [45] Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing Increase in Equivocal Results and Utility of Reflex Immunohistochemistry
    Muller, Kristen E.
    Marotti, Jonathan D.
    Memoli, Vincent A.
    Wells, Wendy A.
    Tafe, Laura J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (02) : 247 - 252
  • [46] Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
    Swati Gupta
    Veronique Neumeister
    John McGuire
    Yan S. Song
    Balazs Acs
    Kenneth Ho
    Jodi Weidler
    Wendy Wong
    Brian Rhees
    Michael Bates
    David L. Rimm
    Veerle Bossuyt
    npj Breast Cancer, 5
  • [47] Impact of Genetic Heterogeneity on HER2 Status with Implementation of the 2013 ASCO/CAP HER2 Reporting Guidelines
    Estrada, Monica V.
    Kuba, Maria G.
    Rexer, Brent
    Manning, Suzanne
    Wheeler, Ferrin
    Yenamandra, Ashwini
    Sanders, Melinda E.
    LABORATORY INVESTIGATION, 2016, 96 : 41A - 41A
  • [48] Impact of Genetic Heterogeneity on HER2 Status with Implementation of the 2013 ASCO/CAP HER2 Reporting Guidelines
    Estrada, Monica V.
    Kuba, Maria G.
    Rexer, Brent
    Manning, Suzanne
    Wheeler, Ferrin
    Yenamandra, Ashwini
    Sanders, Melinda E.
    MODERN PATHOLOGY, 2016, 29 : 41A - 41A
  • [49] Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
    Kamaljeet Singh
    Umadevi Tantravahi
    Michele M. Lomme
    Terese Pasquariello
    Margaret Steinhoff
    C. James Sung
    Breast Cancer Research and Treatment, 2016, 157 : 405 - 411
  • [50] Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
    Singh, Kamaljeet
    Tantravahi, Umadevi
    Lomme, Michele M.
    Pasquariello, Terese
    Steinhoff, Margaret
    Sung, C. James
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 405 - 411
12345